Literature DB >> 19296011

PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.

R Khadgawat1, Y Singh, S Kansara, N Tandon, C Bal, A Seith, P Kotwal.   

Abstract

Oncogenic osteomalacia, or tumour-induced osteomalacia (TIO), is a rare paraneoplastic syndrome characterised by hypophosphataemia, phosphaturia, inappropriately low serum levels of 1,25-dihydroxyvitamin D for hypophosphataemia. TIO is caused by mesenchymal tumours that secrete phosphaturic substances, leading to increased renal wasting of phosphates. These tumours are very small in size and grow slowly. Localisation of these tumours has always been difficult with the available biochemical and imaging techniques. At times, despite all efforts, the tumour could not be localised. We report our experience with a 42-year-old woman with TIO where whole-body magnetic resonance imaging could not localise the tumour, a scapular haemangiopericytoma. PET/CT was helpful in the localisation of the tumour which, when surgically removed, resulted in the normalisation of biochemical parameters with clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296011

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  16 in total

Review 1.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 2.  Heritable and acquired disorders of phosphate metabolism: Etiologies involving FGF23 and current therapeutics.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Bone       Date:  2017-01-31       Impact factor: 4.398

3.  Tumor-induced osteomalacia.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Expert Rev Endocrinol Metab       Date:  2009-09-01

4.  Tumor-induced osteomalacia: experience from a South American academic center.

Authors:  G González; R Baudrand; M F Sepúlveda; N Vucetich; F J Guarda; P Villanueva; O Contreras; A Villa; F Salech; L Toro; L Michea; P Florenzano
Journal:  Osteoporos Int       Date:  2017-03-25       Impact factor: 4.507

5.  F18-fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma.

Authors:  Yiyan Liu
Journal:  Mol Clin Oncol       Date:  2017-10-18

6.  Using (18)F-FDG PET/CT to Detect an Occult Mesenchymal Tumor Causing Oncogenic Osteomalacia.

Authors:  Hyo Jung Seo; Yun Jung Choi; Hyun Jeong Kim; Yong Hyu Jeong; Arthur Cho; Jae Hoon Lee; Mijin Yun; Jong Doo Lee; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2011-07-14

7.  Metastatic recurrence of an intracranial hemangiopericytoma 8 years after treatment: report of a case with emphasis on the role of PET/CT in follow-up.

Authors:  Nilendu C Purandare; Sumeet G Dua; Bharat Rekhi; Sneha Shah; Anshu R Sharma; Venkatesh Rangarajan
Journal:  Cancer Imaging       Date:  2010-05-08       Impact factor: 3.909

8.  Oncogenic osteomalacia: A reversible metabolic bone disorder.

Authors:  Dinesh Kumar Dhanwal
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

9.  Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.

Authors:  Deepa Singh; Aditi Chopra; Mudalsha Ravina; Srikant Kongara; Eesh Bhatia; Narvesh Kumar; Sushil Gupta; Subhash Yadav; Preeti Dabadghao; Rajnikant Yadav; Veeresh Dube; Utham Kumar; Manish Dixit; Sanjay Gambhir
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

10.  Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.

Authors:  David A Shustik; David Ce Ng; Kesavan Sittampalam
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.